benoxathian has been researched along with naphazoline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allard, N; Fuchs, R; Haas, HS; Leitinger, G; Sadjak, A; Schauenstein, K; Schraml, E; Stelzer, I | 1 |
1 other study(ies) available for benoxathian and naphazoline
Article | Year |
---|---|
α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Apoptosis; Autophagy; Caspase 3; Cell Aggregation; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Interactions; Erythroid Cells; Erythroid Precursor Cells; Fetal Blood; Gene Expression; Glycophorins; Hemin; Hemoglobins; Humans; Hydrogen-Ion Concentration; K562 Cells; Leukemia, Erythroblastic, Acute; Leukocyte Common Antigens; Megakaryocyte Progenitor Cells; Megakaryocytes; Naphazoline; Necrosis; Oxathiins; Prazosin; Receptors, Adrenergic, alpha-1 | 2011 |